Nanovibronix Inc

Nanovibronix Inc (NAOV) Stock Analysis

$4.020

-0.271 (-6.73%)At close

Loading chart…
High
4.250
Open
4.100
VWAP
4.09
Vol
32.87K
Mkt Cap
1.98M
Low
4.010
Amount
134.54K
EV/EBITDA, TTM
0.00

ENvue Medical, Inc., formerly NanoVibronix, Inc., is a medical technology company advancing both non-invasive and minimally invasive solutions across clinical and home care settings. The Company focuses on two distinct technology platforms: Acoustic-based therapeutic technologies, including PainShield and UroShield, which utilize proprietary low-intensity surface acoustic wave (SAW) technology. These devices are intended for use in home or care settings and are designed to treat pain, reduce bacterial colonization, and disrupt biofilms. UroShield is an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters. The ENvue Navigation Platform, which is a minimally invasive electromagnetic navigation system intended to assist clinicians in placing feeding tubes into the gastrointestinal tract. ENvue provides real-time bedside visualization of tube movement and supports informed decision-making during the placement procedure.

Valuation Metrics

The current forward P/E ratio for Nanovibronix Inc (NAOV) is -0.00, compared to its 5-year average forward P/E of -0.45.

Forward P/E

Fair
5Y Average P/E
-0.45
Current P/E
-0.00
Overvalued
0.21
Undervalued
-1.11

Forward EV/EBITDA

Strongly Undervalued
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued
0.00
Undervalued
0.00

Forward P/S

Fair
5Y Average P/S
2.38
Current P/S
0.00
Overvalued
5.87
Undervalued
-1.12

Events Timeline

2025-12-12 (ET)

08:10:00

NanoVibronix Changes Name to ENvue Medical and Ticker to FEED

2025-09-15 (ET)

08:10:41

NanoVibronix Receives Patent Approval from USPTO

2025-09-04 (ET)

08:11:07

NanoVibronix's subsidiary receives patent approval

2025-08-08 (ET)

09:08:54

NanoVibronix announces reverse stock split

2025-06-24 (ET)

08:05:34

NanoVibronix to sell two ENvue Navigation Systems to hospital in New York

News

NAOV FAQ — answered by Alphio AI

ENvue Medical, Inc., formerly NanoVibronix, Inc., is a medical technology company advancing both non-invasive and minimally invasive solutions across clinical and home care settings. The Company focuses on two distinct technology platforms: Acoustic-based therapeutic technologies, including PainShield and UroShield, which utilize proprietary low-intensity surface acoustic wave (SAW) technology. These devices are intended for use in home or care settings and are designed to treat pain, reduce bacterial colonization, and disrupt biofilms. UroShield is an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters. The ENvue Navigation Platform, which is a minimally invasive electromagnetic navigation system intended to assist clinicians in placing feeding tubes into the gastrointestinal tract. ENvue provides real-time bedside visualization of tube movement and supports informed decision-making during the placement procedure. It operates in the Healthcare sector (ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUP industry).

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Get Started